PATENT CLAIM ANALYSIS

Application Number: 16025764
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "470000"]

Abstract:
A method for decreasing the incidence rate and/or recurrent rate of cancer is provided. The method comprises administering to a subject in need an effective amount of butylidenephthalide (BP).

Claim (Index 2):
The method as claimed in  claim 1 , wherein the method is for preventing, mitigating and/or inhibiting the growth, migration and/or invasion of cancer stem cell (CSC).

Metadata:
- Claim Count in Document: 18.0
- Percentile: 95.0
- Lexical Diversity: 1.13793
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13671274', '15774208', '12830993', '14982519', '14376923']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7593902973359389
- 35 USC 102 Novelty (BERT): 0.5116329648178851
- Combined Prediction Score: 0.7346145640841335
- Mean Citation Score: 228.790326
- Max Citation Score: 251.4584
- Similarity Product: 158.80080720338822

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test